ABDUL QADIR: Open Payments
NPI 1902809742 · PLEASANTVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$324 in 14 payments from 10 companies in 2025. Trend: 2023 $627 · 2024 $709 · 2025 $324
Food & beverage: $324
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| Exact Sciences Corporation | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Smith+Nephew, Inc. | 1 | $14 |
Products named: BREZTRI, Kerendia, RELISTOR, REXULTI, Cologuard Collection Kit, JARDIANCE, PAXLOVID, COLLAGENASE SANTYL.
Industry payments across NJ — which companies pay providers there.
